🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Maryland › Baltimore

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Baltimore, MD

8 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Ap rekriteFaz 3
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ap rekriteFaz 2
  • Johns Hopkins University, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Ap rekriteFaz 1/2
  • Johns Hopkins University ( Site 0055), Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT06637423

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • Johns Hopkins Kimmel Cancer Center, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Ap rekriteFaz 3
  • Johns Hopkins University (Data Collection Only), Baltimore
Laj 21 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06929286

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • John Hopkins Hospital, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Ap rekriteFaz 1/2
  • Anna Arundel Urology, Annapolis · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848

Blue Light Cystoscopy With Cysview® Registry

Ap rekriteEtid obsèvasyon
  • Johns Hopkins Medicine, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Etid Kansè Vezik ki pa envazif miskilè nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.